Tavaborole Patent Expiration
Tavaborole is Used for treating onychomycosis (fungal infection of the toenail). It was first introduced by Anacor Pharmaceuticals Inc
Tavaborole Patents
Given below is the list of patents protecting Tavaborole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kerydin |
US7582621 (Pediatric) | Boron-containing small molecules | Nov 26, 2027 | Anacor Pharms Inc |
| Kerydin | US7582621 | Boron-containing small molecules | May 26, 2027 | Anacor Pharms Inc |
| Kerydin | US7767657 | Boron-containing small molecules | May 22, 2027 | Anacor Pharms Inc |
| Kerydin |
US9549938 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9566289 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9566290 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9572823 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9549938 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9566289 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9566290 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9572823 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
Tavaborole's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List